Helius Medical Technologies is trading at $3.52, up 7.65% in pre-market after B. Riley Securities maintained its Buy rating and raised its price target from $3.50 to $4.00 on September 22, 2026.
- The analyst action follows recent momentum; major U.S. indexes were nearly flat overnight.
- No earnings release, regulatory decision, or other major corporate announcement was identified for September 23, 2026.